Retina Times
- From the President
- Leadership in Times of Uncertainty—Arguably What the ASRS Does Best
- Timothy G. Murray, MD, MBA
- From the Editor's Desk
- A Pandemic Brings Me Face to Face With My Issues
- Sunir J. Garg, MD, FACS
- Special Report: Telemedicine
- COVID-19 Pandemic Induces Surge in Telemedicine
- Sunir J. Garg, MD, FACS
- Innovation and Entrepreneurship
- How Can You Protect Your Invention Idea? A Primer on Patent Applications
- Allison L. Richmond, JD , Daniel L. Chao, MD, PhD , Jeffrey G. Gross, MD
- ReST Committee Report
- Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab: An ASRS Research and Safety in Therapeutics (ReST) Committee Report
- Andre J. Witkin, MD , Paul Hahn, MD, PhD , Timothy G. Murray, MD, MBA, FACS
- In Memoriam
- Honoring Two Esteemed Retina Specialists
- US Report
- PART 2: A Follow-Up Look at the Impact of the COVID-19 Pandemic on US Retina Practices
- J. Michael Jumper, MD
- Reflections
- April Reflections From Lockdown in New York City
- Roy A. Levit, MD
- International Report
- PART 2
COVID-19: Up Close and Personal—The Road to Recovery - Retinomics Online-First: Annual Meeting 2020
- Tracking the Impact of COVID-19 on the Retina Community
- Larry Halperin, MD , Richard A. Garfinkel, MD
- What's News
- NYC Retina Specialists Answer the Call to Volunteer in Hospitals Amid the COVID-19 Pandemic
- Dilsher S. Dhoot, MD , Dante J. Pieramici, MD , Audina M. Berrocal, MD
- Clinical Trials: Future Pathways
- Faricimab for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration –Can we do better by targeting both angiopoietin-2 and vascular endothelial growth factor?
- Nathan C. Steinle, MD , Yvonne N. Okaka, MD , Lauren Hayashi, MS , Chirag P. Shah, MD, MPH
- Special Report
- Why Are Institutional Review Boards Important—and When Do You Need One?
- Chirag P. Shah, MD, MPH
- Practice Management
- Surviving the Business Impact of COVID-19: Be Sure to Understand the Fine Print
- Kristin Yockus, MPH , David Gavin, MBA , Allison W. Shuren, JD
- Retinomics
- Retina Drugs in 2020: A Health Care Policy Perspective on Pricing
- Larry Halperin, MD , Richard A. Garfinkel, MD
- Pediatric Retina
- How is the Pandemic Affecting ROP Screening and Treatment?
- R.V. Paul Chan, MD , Audina M. Berrocal, MD
- Research & Development
- PART 4 IN A SERIES
Cell Therapy: What Lies Ahead? - Pravin U. Dugel, MD
- Block Time
- Vitrectomy for Retinal Detachment Repair: Techniques for Success
- Jason Hsu, MD , Mitchell S. Fineman, MD
- The KOL Corner
- Employing Newer Macular Hole Surgical Techniques
- Marc J. Spirn, MD , Carl D. Regillo, MD, FACS
- The Best is Yet to Be
- 'May You Live in Interesting Times'
–Ancient Curse of Apocryphal Origin - Allen Z. Verne, MD
- Jerry's Wisdom
- Squeeze the Soap Like Xiomara
- Jerald A. Bovino, MD
- The ASRS X-Files
- The ASRS X-Files
- Kirk K. Hou, MD, PhD , Edmund Tsui, MD , David Sarraf, MD
- Literature Roundup
- LITERATURE ROUNDUP
- Joseph D. Boss, MD , Joseph Raevis, MD , Michael M. Altaweel, MD , Asheesh Tewari, MD
- Early Career Section
- Establishing a Niche in Retina
- Aleksandra V. Rachitskaya, MD , Ankoor R. Shah, MD
- Ocular Oncology
- What Happens to Patients With Ocular Tumors During the Coronavirus Pandemic?
- J. William Harbour, MD , Zelia M. Correa, MD, PhD
Current Issue
Summer 2020
Issue 84, Volume 38, No. 2
Download
About Retina Times
Retina Times is published five times a year by the American Society of Retina Specialists (ASRS) as a service to its membership.
Some content on this page is restricted to access by members only. Login to view full page.